Takeda Pharma unlikely to sell OTC drug business, says CEO

Takeda Pharma unlikely to sell OTC drug business, says CEO

REUTERS/Arnd Wiegmann

Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it closes a $59 billion takeover of London-listed Shire, Chief Executive Christophe Weber said on Monday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter